152 related articles for article (PubMed ID: 3518311)
1. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
[TBL] [Abstract][Full Text] [Related]
2. [Leukocyte migration inhibition test in multiple sclerosis - results of a migration technic according to Clausen using brain specific antigens].
Lehmitz R; Meyer-Rienecker HJ; Werner H; Eichler R
Psychiatr Neurol Med Psychol (Leipz); 1980 Oct; 32(10):577-87. PubMed ID: 6164068
[TBL] [Abstract][Full Text] [Related]
3. [Cell migration inhibition factor in the presence of lung extract in patients with productive pulmonary tuberculosis].
Bernal-Madrazo MA; Celis-Barragán ME; Olivares-Lugo A; Cicero-Sabido R
Gac Med Mex; 1982 Jun; 118(6):236-8. PubMed ID: 6751919
[No Abstract] [Full Text] [Related]
4. [Effect of serum fractions from cancer patients on leukocyte migration out of capillary tubes].
Novikov DK; Shmakov AP; Borisenko ID
Biull Eksp Biol Med; 1978 Nov; 86(11):568-72. PubMed ID: 363203
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
Crivii SM; Crişan M; Crişan M
Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
[TBL] [Abstract][Full Text] [Related]
8. "In vitro" and "in vivo" leukocyte migration inhibitory factor production in acute infectious mononucleosis patients.
Bertotto A; Gentili F; Stagni G; Zucchetti Z; Vaccaro R
Boll Ist Sieroter Milan; 1983 Jul; 62(3):281-6. PubMed ID: 6357231
[TBL] [Abstract][Full Text] [Related]
9. [Production of the leukocyte inhibitory factor (LIF) by peripheral blood lymphocytes in vitro and LIF-like plasma activity in paraproteinemic patients].
Puppo F; Corsini G; Mangini P; Armani U; Piana A
Haematologica; 1984; 69(4):394-402. PubMed ID: 6437916
[No Abstract] [Full Text] [Related]
10. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
Kijlstra A; Broersma L
Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
[TBL] [Abstract][Full Text] [Related]
11. Increased migration inhibition factor production by leukocytes of patients with herpes zoster given the leukocyte ultrafiltrate.
Lackovicová M; Zachar V; Necas S; Mayer V
Acta Virol; 1989 Sep; 33(5):428-34. PubMed ID: 2576583
[TBL] [Abstract][Full Text] [Related]
12. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
13. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
Sheremata W; Triller H; Cosgrove JB; Eylar EH
Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
Dachsel R; Felber F; Liebert A
Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061
[TBL] [Abstract][Full Text] [Related]
15. Serum migration-inhibitory activity in patients with acute leukemia and early leukemic lymphosarcoma.
Fassas A; Bruley-Rosset M; Guibout C; Jasmin C
Clin Immunol Immunopathol; 1979 Nov; 14(3):368-78. PubMed ID: 387315
[No Abstract] [Full Text] [Related]
16. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
Lou J; Gasche Y; Zheng L; Giroud C; Morel P; Clements J; Ythier A; Grau GE
Lab Invest; 1999 Aug; 79(8):1015-25. PubMed ID: 10462039
[TBL] [Abstract][Full Text] [Related]
17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
18. [Leukocyte migration inhibition factor in acne vulgaris].
Vignale RA; Lasalvia E; Paciel J
Med Cutan Ibero Lat Am; 1980; 8(4-6):101-3. PubMed ID: 6456387
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
McCandless EE; Klein RS
Expert Rev Mol Med; 2007 Jul; 9(20):1-19. PubMed ID: 17637110
[TBL] [Abstract][Full Text] [Related]
20. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
